SEARCH RESULT

Total Matching Records found : 59

Health ministry moots online sale of drugs; regulator works on guidelines -Sushmi Dey

-The Times of India NEW DELHI: As online shopping catches up, you could buy medicines too with a click of the mouse for which the health ministry is evaluating a proposal. The drug quality regulator is framing guidelines and mechanism to monitor such sale. The proposal is expected to be taken up for discussion in the drugs consultative committee meeting next month, a senior regulatory official said. At present, the Drugs & Cosmetics...

More »

Wither Away the Pressure on India's Patent Law -Saradindu Bhaduri

-Vikalp Once again, India is under pressure from the US to revise its patent law. Anyone familiar with the activities of the United States Trade Representatives (USTR) would know that this is nothing new. It has been among the USTR's primary mandates to use trade restrictions in order to persuade (to put it mildly) countries to strengthen their IPR laws. There is, however, a qualitative difference between the actions it has...

More »

Why do Indian health authorities keep quiet on pharma firms' failings? -Nivedita Mookerji

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

More »

Anand Grover, Senior advocate and former UN special rapporteur on the right to health speaks to Rema Nagarajan

-The Times of India India's intellectual property (IP) law has been hailed as one of the most progressive for safeguarding public interest, and several nations like Argentina, the Philippines and Brazil are looking to learn from it. Senior advocate and former UN special rapporteur on the right to health Anand Grover talks to Rema Nagarajan about the pressure the country is facing to change its IP laws, primarily from the US. *...

More »

Billing for wallet shock -Digbijay Mishra

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close